The discovery of hereditary breast-ovarian cancer genes was initially viewed as an advance in preventive medicine, with the focus on timely cancer diagnosis and prophylactic surgery applied to BRCA1/2 mutation carriers. The gene discussed is BRCA1; the disease is cancer.